Latest News

  • Alkermes Announces Initiation of Study 217 for ALKS 5461 for Treatment of Major Depressive Disorder Read More
  • Alkermes to Present at Goldman Sachs 38th Annual Global Healthcare Conference Read More
  • Alkermes Announces Initiation of Phase 3 Study of ALKS 3831 in Young Adult Patients Read More

Investors

Learn more Learn More Alkermes PLC Investor Relations

Working at Alkermes

Join Our Team Join Our Team Working at Alkermes